[{"Assets_0_Q2_USD":178377000.0,"CommonStockSharesOutstanding_0_Q2_shares":156645863.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-45417000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":6834000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":2763000.0,"StockholdersEquity_0_Q2_USD":128047000.0,"Ticker":"CLDX","CIK":"744218","name":"CELLDEX THERAPEUTICS, INC.","OfficialName":"Celldex Therapeutics Inc.","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1601609341.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20180808"}]